Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly sales of $6.13 million which beat the analyst consensus estimate of $5.98 million by 2.51 percent.
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly sales of $6.13 million which beat the analyst consensus estimate of $5.98 million by 2.51 percent.